Advertisement
Home Blog Page 3538
A minority of patients discharged with chronic obstructive pulmonary disease receive pharmacologic treatment for tobacco use

Few Get Rx to Help Quit Smoking After COPD Hospitalization

0
Treatment not associated with cessation at six to 12 months; differences between medications
In order to prevent denials

Specific, Consistent ICD-10 Coding Key to Timely Payments

0
Tips to prevent denials include checking EHR selection against documentation, being specific
Patients with sudden cardiac arrest frequently have warning symptoms

Many Ignore Warning Symptoms Before Sudden Cardiac Arrest

0
Survival significantly higher for patients who call emergency services in response to symptoms
For patients with hip and knee osteoarthritis

Combined Patient, Physician Intervention Ups Function in OA

0
Modest improvement in WOMAC, WOMAC function subscale for patients with hip, knee osteoarthritis
Transference-focused psychotherapy is associated with alterations in frontolimbic circuitry in borderline personality disorder

Neural Effects of Psychotherapy in Personality Disorder ID’d

0
TFP associated with alterations in frontolimbic circuitry in borderline personality disorder

Meta-Analysis Confirms miR-21 Expression, Laryngeal CA Link

0
High miR-21 expression seen in laryngeal cancer versus non-neoplasm tissue
U.S. hematologists frequently report that the timing of end of life discussions is "too late

Hematologists Often Initiate End-of-Life Discussions Too Late

0
Respondents in tertiary care centers more likely to report late discussions versus community centers
For patients with type 1 diabetes

Intranasal Glucagon Treats Hypoglycemia in Type 1 Diabetes

0
Noninferior to IM glucagon for treating insulin-induced hypoglycemia in adults with type 1 diabetes
Periodontal disease is associated with increased risk of breast cancer among postmenopausal women

Periodontal Disease Linked to Increased Breast Cancer Risk

0
Increased risk of postmenopausal breast cancer, especially for smokers who quit within last 20 years
Pembrolizumab (Keytruda) may extend survival for patients with advanced non-small-cell lung cancer

Pembrolizumab Shows Promise in Metastatic NSCLC

0
In study, the immune-based therapy beat docetaxel with fewer side effects